On the U.K. business, the company announced that it has agreed to pay over $1.5 billion to settle a long-running legal action brought by the U.S. Attorney's Office for the Southern District of New York.  The settlement is subject to court approval.  The SEC's complaint, filed in federal court in New York, alleges that the U.K. Department of Health and Human Services (DOH) and Department of Health and Human Services (HHS) violated the antifraud provisions of Section 17(a) of the Securities Act of 1933 ("Securities Act") and Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 thereunder.  Without admitting or denying the allegations in the SEC's complaint, DOH and HHS agreed to settle the matter without admitting or denying the allegations in the complaint. The settlement is subject to court approval.  In a parallel action, the U.S. Attorney's Office today announced criminal charges against DOH and HHS.  The SEC's complaint charges DOH and HHS with violating Section 10(b) of the Exchange Act and Rule 10b-5 thereunder. Without admitting or denying the SEC's allegations, DOH and HHS have agreed to settle the charges without admitting or denying the allegations in the SEC complaint. The settlement is subject to Court approval.  The SEC appreciates the assistance of the U.S. Attorney's Office for New York, the Department of Health and Human Services, the Federal Bureau of Investigation, and the Financial Industry Regulatory Authority.